BIO Protocol announced via a post on X that Long COVID Labs launches tomorrow, January 9, and it will accelerate a cure with DeSci.
The ticker of the project will be COVID and contributors include current and ex-Stanford researchers. The project will distribute 1% of the token supply to BIO holders who take part in the auction.
The project revealed via X important details about their vision, starting by saying that even if COVID-19 left the headlines, it never left peoples’ bodies. They addressed that 20% of recovered patients still have viral remnants including spike proteins in their bloodstream.
Also, they noted that 40% of people diagnosed with long Covid suffer from chronic illness.
Long COVID Labs was reportedly created to tackle these challenges with a bold vision:
The founders of the project include the following specialists:
In the X thread, the project claims to be the largest decentralized trial network ever built, involving machine learning that:
The project also noted that while Big Pharma ruled medicine for decades, profiting from slow and expensive processes that prioritize investors over patients, now Long COVID Labs will change this paradigm, focusing on patients.
The project uses a DAO model where individuals/patients hold governance tokens (COVID) that allow them to vote on proposals, recommend research directions, and oversee financial proceeds.
There are two ways to earn COVID tokens:
The BIO Protocol was announced as Binance Launchpool’s 63rd project in December 2024.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。